Bank of America’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-308,007
Closed -$11.8M 7040
2023
Q2
$11.8M Sell
308,007
-6,668
-2% -$256K ﹤0.01% 2166
2023
Q1
$7.28M Buy
314,675
+139,652
+80% +$3.23M ﹤0.01% 2682
2022
Q4
$4.59M Buy
175,023
+35,910
+26% +$941K ﹤0.01% 2961
2022
Q3
$2.74M Buy
139,113
+54,819
+65% +$1.08M ﹤0.01% 3401
2022
Q2
$1.48M Buy
84,294
+18,171
+27% +$318K ﹤0.01% 3941
2022
Q1
$1.08M Sell
66,123
-151,662
-70% -$2.48M ﹤0.01% 4494
2021
Q4
$3.55M Buy
217,785
+1,373
+0.6% +$22.4K ﹤0.01% 3427
2021
Q3
$2.76M Sell
216,412
-58
-0% -$740 ﹤0.01% 3536
2021
Q2
$3.06M Buy
216,470
+52,259
+32% +$738K ﹤0.01% 3421
2021
Q1
$2.55M Buy
164,211
+6,116
+4% +$95K ﹤0.01% 3548
2020
Q4
$2.51M Buy
158,095
+157,900
+80,974% +$2.5M ﹤0.01% 3229
2020
Q3
$2K Sell
195
-838
-81% -$8.6K ﹤0.01% 6051
2020
Q2
$12K Buy
1,033
+849
+461% +$9.86K ﹤0.01% 5798
2020
Q1
$3K Sell
184
-6,615
-97% -$108K ﹤0.01% 5963
2019
Q4
$40K Sell
6,799
-3,362
-33% -$19.8K ﹤0.01% 5488
2019
Q3
$54K Buy
10,161
+191
+2% +$1.02K ﹤0.01% 5470
2019
Q2
$77K Sell
9,970
-1,399
-12% -$10.8K ﹤0.01% 5350
2019
Q1
$227K Sell
11,369
-26,935
-70% -$538K ﹤0.01% 4743
2018
Q4
$505K Buy
38,304
+21,108
+123% +$278K ﹤0.01% 4265
2018
Q3
$632K Buy
17,196
+9,768
+132% +$359K ﹤0.01% 4134
2018
Q2
$260K Buy
7,428
+4,393
+145% +$154K ﹤0.01% 4577
2018
Q1
$141K Sell
3,035
-22,900
-88% -$1.06M ﹤0.01% 4839
2017
Q4
$972K Buy
25,935
+21,409
+473% +$802K ﹤0.01% 3835
2017
Q3
$241K Buy
4,526
+2,069
+84% +$110K ﹤0.01% 4541
2017
Q2
$140K Sell
2,457
-303
-11% -$17.3K ﹤0.01% 4736
2017
Q1
$149K Sell
2,760
-4,683
-63% -$253K ﹤0.01% 4726
2016
Q4
$424K Buy
7,443
+6,367
+592% +$363K ﹤0.01% 4201
2016
Q3
$66K Sell
1,076
-4,859
-82% -$298K ﹤0.01% 4863
2016
Q2
$336K Buy
5,935
+763
+15% +$43.2K ﹤0.01% 4184
2016
Q1
$332K Sell
5,172
-4,381
-46% -$281K ﹤0.01% 4111
2015
Q4
$1.34M Buy
9,553
+4,281
+81% +$602K ﹤0.01% 3360
2015
Q3
$511K Buy
5,272
+3,743
+245% +$363K ﹤0.01% 3901
2015
Q2
$232K Buy
+1,529
New +$232K ﹤0.01% 4233